Skip to main content

Pacific Biosciences Partners with Sage Science to Co-market DNA Size Selection Device

NEW YORK (GenomeWeb News) − Pacific Biosciences has partnered with Sage Science to co-market Sage's BluePippin DNA size selection device for use with the PacBio RS II single-molecule sequencer, the companies said today.

The BluePippin platform enables users to isolate DNA fragments of a specific length, ranging from 50 bases to 50 kilobases, in an automated way that can then be used to generate next-generation sequencing libraries.

Selecting long DNA fragments for library preparation increases the average read length generated on the PacBio RS II.

"We have found that the BluePippin size selection platform is very useful for applications where long read lengths are important, such as de novo genome assembly," said Kevin Corcoran, senior vice president of market development at Pacific Biosciences, in a statement.

Using the BluePippin "is an easy addition to our customers' sample prep workflow to select for 10 [kilobase] or larger fragments for sequencing on the PacBio RS II," he added.

Financial or other terms of the co-marketing agreement were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.